Guangdong Jiaying Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE1000008P1
CNY
3.97
-0.2 (-4.8%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
379.46
368.98
527.43
651.97
564.05
535.22
490.36
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
379.46
368.98
527.43
651.97
564.05
535.22
490.36
Raw Material Cost
160.39
157.84
198.32
242.62
157.08
160.20
121.65
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
48.27
48.62
54.16
53.93
51.81
50.69
58.86
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.23
0.04
0.03
0.49
1.08
4.04
3.52
Selling and Distribution Expenses
164.29
184.30
280.84
341.28
362.05
335.26
346.86
Other Expenses
-4.09
-4.34
-4.56
-4.06
-4.01
-4.63
-4.96
Total Expenditure (Excl Depreciation)
332.29
347.40
487.74
597.67
531.86
503.86
481.34
Operating Profit (PBDIT) excl Other Income
47.199999999999996
21.6
39.7
54.3
32.2
31.400000000000002
9
Other Income
0.26
8.42
5.69
4.67
3.45
0.88
2.87
Operating Profit (PBDIT)
63.86
48.89
65.50
80.82
62.68
58.89
38.26
Interest
0.23
0.04
0.03
0.49
1.08
4.04
3.52
Exceptional Items
-0.01
-0.26
0.65
-2.12
-28.51
0.00
-120.79
Gross Profit (PBDT)
219.07
211.14
329.11
409.36
406.97
375.02
368.71
Depreciation
23.35
19.71
24.21
25.89
28.40
28.19
27.19
Profit Before Tax
40.28
28.89
41.91
52.31
4.70
26.66
-113.24
Tax
7.47
4.48
5.05
7.16
4.35
3.18
8.00
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
30.48
20.61
34.32
43.93
1.48
19.84
-122.18
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
30.48
20.61
34.32
43.93
1.48
19.84
-122.18
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
30.48
20.61
34.32
43.93
1.48
19.84
-122.18
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
717.93
758.22
762.98
728.42
684.48
683.01
663.17
Earnings per share (EPS)
0.06
0.04
0.07
0.09
0.0
0.04
-0.24
Diluted Earnings per share
0.06
0.04
0.07
0.09
0.0
0.04
-0.24
Operating Profit Margin (Excl OI)
10.61%
5.63%
6.75%
7.71%
5.47%
5.57%
1.67%
Gross Profit Margin
16.77%
13.17%
12.54%
11.99%
5.87%
10.25%
-17.55%
PAT Margin
8.03%
5.59%
6.51%
6.74%
0.26%
3.71%
-24.92%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2025 is 2.85% vs -30.03% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2025 is 48.06% vs -39.94% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2025 is 57.04% vs -32.27% in Dec 2024

stock-summary

Interest

YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2025 has improved from Dec 2024

Compare Annual Results Of Guangdong Jiaying Pharmaceutical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
379.46
0
379.46
Other Operating Income
0.00
0.00
0.00
Total Operating income
379.46
0
379.46
Raw Material Cost
160.39
0
160.39
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
48.27
0
48.27
Power Cost
0
0
0.00
Manufacturing Expenses
0.23
0
0.23
Selling and Distribution Expenses
164.29
0
164.29
Other Expenses
-4.09
0.00
-4.09
Total Expenditure (Excl Depreciation)
332.29
0
332.29
Operating Profit (PBDIT) excl Other Income
47.17
0.00
47.17
Other Income
0.26
0
0.26
Operating Profit (PBDIT)
63.86
0
63.86
Interest
0.23
0
0.23
Exceptional Items
-0.01
0
-0.01
Gross Profit (PBDT)
219.07
0
219.07
Depreciation
23.35
0
23.35
Profit Before Tax
40.28
0
40.28
Tax
7.47
0
7.47
Provisions and contingencies
0
0
0.00
Profit After Tax
30.48
0
30.48
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
30.48
0
30.48
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
30.48
0
30.48
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
717.93
0
717.93
Earnings per share (EPS)
0.06
0
0.06
Diluted Earnings per share
0.06
0
0.06
Operating Profit Margin (Excl OI)
10.61%
0%
0.00
10.61%
Gross Profit Margin
16.77%
0%
0.00
16.77%
PAT Margin
8.03%
0%
0.00
8.03%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 37.95 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 2.85% vs -30.03% in Dec 2024

Annual - Consolidate Net Profit
Consolidate Net Profit 3.05 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 48.06% vs -39.94% in Dec 2024

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 6.36 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 57.04% vs -32.27% in Dec 2024

Annual - Interest
Interest 0.02 Million
in Dec 2025

Figures in Million
stock-summary

YoY Growth in year ended Dec 2025 is 0.00% vs 0.00% in Dec 2024

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 10.61%
in Dec 2025

Figures in %
stock-summary

YoY Growth in year ended Dec 2025 has improved from Dec 2024